Latest news
Tonix Pharmaceuticals Announces FDA Alignment on 3,300‑Participant Adaptive Phase 2 Lyme Study; TNX-4800 Dosing, 2027 Site Delivery - TradingViewTradingView · Mon, 03 Aug 2026 11:23:01 GMTTonix Pharmaceuticals Announces FDA Alignment on Phase 2 Study Design for TNX-4800 Lyme Disease Prevention Trial - Quiver QuantitativeQuiver Quantitative · Mon, 03 Aug 2026 11:15:00 GMTMeitheal Pharmaceuticals Announces FDA Approval of Garzulys™ (insulin aspart-fsan) Injection - Business WireBusiness Wire · Thu, 30 Jul 2026 07:00:00 GMTCorbus Pharmaceuticals Announces FDA Clearance to Initiate - GlobeNewswireGlobeNewswire · Tue, 28 Jul 2026 12:00:00 GMT